TLR10 Suppresses the Activation and Differentiation of Monocytes with Effects on DC-mediated Adaptive Immune Responses

Overview

Journal J Leukoc Biol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 2017 Feb 26

PMID 28235773

Citations 15

Authors

Nicholas J Hess

Christopher Felicelli

Jennifer Grage

Richard I Tapping

Affiliations

Soon will be listed here.

Abstract

TLRs are important pattern-recognition receptors involved in the activation of innate immune responses against foreign pathogens. TLR10 is the only TLR family member without a known ligand, signaling pathway, or clear cellular function. Previous work has shown that TLR10 suppresses proinflammatory cytokine production in response to TLR agonists in a mixed human mononuclear cell population. We report that TLR10 is preferentially expressed on monocytes and suppresses proinflammatory cytokine production resulting from either TLR or CD40 stimulation. TLR10 engagement affects both the MAPK and Akt signaling pathways, leading to changes in the transcriptome of isolated human monocytes. Differentiation of monocytes into dendritic cells in the presence of an αTLR10 mAb reduced the expression of maturation markers and the induction of proinflammatory cytokines, again in response to either TLR or CD40 stimulation. Finally, in coculture experiments, TLR10 differentiated dendritic cells exhibited a decreased capacity to activate T cells as measured by IL-2 and IFN-γ production. These data demonstrate that TLR10 is a novel regulator of innate immune responses and of the differentiation of primary human monocytes into effective dendritic cells.

Citing Articles

Blood gene expression of Toll-like receptors in SLE patients with lupus nephritis or neuropsychiatric systemic lupus erythematosus.

Dudkova M, Petrackova A, Radvansky M, Skacelova M, Videman J, Manakova J Arthritis Res Ther. 2025; 27(1):41.

PMID: 40011954 PMC: 11863772. DOI: 10.1186/s13075-025-03512-z.

TLR10 (CD290) Is a Regulator of Immune Responses in Human Plasmacytoid Dendritic Cells.

Deb P, Singh S, Kalyoussef E, Hess N, Tapping R, Fitzgerald-Bocarsly P J Immunol. 2024; 213(5):577-587.

PMID: 38995177 PMC: 11333166. DOI: 10.4049/jimmunol.2200468.

Role of Innate Immunity in Allergic Contact Dermatitis: An Update.

Yamaguchi H, Yamaguchi Y, Peeva E Int J Mol Sci. 2023; 24(16).

PMID: 37629154 PMC: 10455292. DOI: 10.3390/ijms241612975.

Toll-like receptor 10 is down-regulated in serum of patients with relapsing-remitting multiple sclerosis but not associated with Epstein-Barr virus.

Atiyah N, Fadhil H, Adhiah A J Neurovirol. 2023; 29(2):203-210.

PMID: 36934201 DOI: 10.1007/s13365-023-01124-4.

Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases.

Liu J, Zhang H, Su Y, Zhang B Cell Biosci. 2022; 12(1):68.

PMID: 35619184 PMC: 9134593. DOI: 10.1186/s13578-022-00810-w.

References

Panneerselvam P, Ding J . Beyond TLR Signaling—The Role of SARM in Antiviral Immune Defense, Apoptosis & Development. Int Rev Immunol. 2015; 34(5):432-44. DOI: 10.3109/08830185.2015.1065826. View

Xiong H, Pamer E . Monocytes and infection: modulator, messenger and effector. Immunobiology. 2014; 220(2):210-4. PMC: 4404758. DOI: 10.1016/j.imbio.2014.08.007. View

Kawai T, Akira S . The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010; 11(5):373-84. DOI: 10.1038/ni.1863. View

Gay N, Symmons M, Gangloff M, Bryant C . Assembly and localization of Toll-like receptor signalling complexes. Nat Rev Immunol. 2014; 14(8):546-58. DOI: 10.1038/nri3713. View

Mourao-Sa D, Roy S, Blander J . Vita-PAMPs: signatures of microbial viability. Adv Exp Med Biol. 2013; 785:1-8. DOI: 10.1007/978-1-4614-6217-0_1. View

Oosting M, Cheng S, Bolscher J, Vestering-Stenger R, Plantinga T, Verschueren I . Human TLR10 is an anti-inflammatory pattern-recognition receptor. Proc Natl Acad Sci U S A. 2014; 111(42):E4478-84. PMC: 4210319. DOI: 10.1073/pnas.1410293111. View

Krawczyk C, Holowka T, Sun J, Blagih J, Amiel E, DeBerardinis R . Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood. 2010; 115(23):4742-9. PMC: 2890190. DOI: 10.1182/blood-2009-10-249540. View

Jiang S, Li X, Hess N, Guan Y, Tapping R . TLR10 Is a Negative Regulator of Both MyD88-Dependent and -Independent TLR Signaling. J Immunol. 2016; 196(9):3834-41. PMC: 4868647. DOI: 10.4049/jimmunol.1502599. View

Lin S, Lo Y, Wu H . Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature. 2010; 465(7300):885-90. PMC: 2888693. DOI: 10.1038/nature09121. View

10.

Troutman T, Hu W, Fulenchek S, Yamazaki T, Kurosaki T, Bazan J . Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/Akt. Proc Natl Acad Sci U S A. 2011; 109(1):273-8. PMC: 3252926. DOI: 10.1073/pnas.1118579109. View

11.

Roach J, Glusman G, Rowen L, Kaur A, Purcell M, Smith K . The evolution of vertebrate Toll-like receptors. Proc Natl Acad Sci U S A. 2005; 102(27):9577-82. PMC: 1172252. DOI: 10.1073/pnas.0502272102. View

12.

Chuang T, Ulevitch R . Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta. 2001; 1518(1-2):157-61. DOI: 10.1016/s0167-4781(00)00289-x. View

13.

Mikacenic C, Reiner A, Holden T, Nickerson D, Wurfel M . Variation in the TLR10/TLR1/TLR6 locus is the major genetic determinant of interindividual difference in TLR1/2-mediated responses. Genes Immun. 2012; 14(1):52-7. PMC: 3554851. DOI: 10.1038/gene.2012.53. View

14.

Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T . Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol. 2002; 168(9):4531-7. DOI: 10.4049/jimmunol.168.9.4531. View

15.

Regan T, Nally K, Carmody R, Houston A, Shanahan F, MacSharry J . Identification of TLR10 as a key mediator of the inflammatory response to Listeria monocytogenes in intestinal epithelial cells and macrophages. J Immunol. 2013; 191(12):6084-92. DOI: 10.4049/jimmunol.1203245. View

16.

Wu Y, Kumar R, Iida R, Bagavant H, Alarcon-Riquelme M . BANK1 Regulates IgG Production in a Lupus Model by Controlling TLR7-Dependent STAT1 Activation. PLoS One. 2016; 11(5):e0156302. PMC: 4882053. DOI: 10.1371/journal.pone.0156302. View

17.

den Haan J, Arens R, van Zelm M . The activation of the adaptive immune system: cross-talk between antigen-presenting cells, T cells and B cells. Immunol Lett. 2014; 162(2 Pt B):103-12. DOI: 10.1016/j.imlet.2014.10.011. View

18.

Mikami T, Miyashita H, Takatsuka S, Kuroki Y, Matsushima N . Molecular evolution of vertebrate Toll-like receptors: evolutionary rate difference between their leucine-rich repeats and their TIR domains. Gene. 2012; 503(2):235-43. DOI: 10.1016/j.gene.2012.04.007. View

19.

Kawasaki T, Kawai T . Toll-like receptor signaling pathways. Front Immunol. 2014; 5:461. PMC: 4174766. DOI: 10.3389/fimmu.2014.00461. View

20.

Jenkins K, Mansell A . TIR-containing adaptors in Toll-like receptor signalling. Cytokine. 2009; 49(3):237-44. DOI: 10.1016/j.cyto.2009.01.009. View